Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a …

H Andresen, B Sasko, D Patschan, N Pagonas… - Journal of Medical Case …, 2021 - Springer
… Furthermore, due to the optimal shock vector (anteroposterior … antitachycardia pacing may
also succeed, but this treatment … the management of patients with ventricular arrhythmias and …

The past, present, and future of implantable cardioverter-defibrillators

RP Jones II, RD Berger - Emerging Technologies for Heart Diseases, 2020 - Elsevier
… (SCD) for patients with prior ventricular arrhythmias (VAs) or at … antitachycardia pacing to
cardiac resynchronization therapy. … Optimal implantable cardioverter defibrillator programming …

[HTML][HTML] Contemporary management of heart failure patients with reduced ejection fraction: the role of implantable devices and catheter ablation

C Sohrabi, S Ahsan, A Briasoulis… - Reviews in …, 2021 - imrpress.com
treating VT or VF via an implantable cardioverter-defibrillator … to LVAD therapy versus optimal
medical therapy. Although all-… therapies are used to terminate VT by antitachycardia pacing

Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study

R Garcia, N Combes, P Defaye, K Narayanan… - EP …, 2021 - academic.oup.com
… , post-implantable cardioverter-defibrillator extraction in 119 … During the first 30 days of
use, 26 ventricular arrhythmias (… implanted with an ICD after optimization of pharmacological …

ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac …

G Casolo, MM Gulizia, D Aschieri… - European Heart …, 2023 - academic.oup.com
… eg during optimization of pharmacological therapy and during the … of use), while the efficacy
in treating ventricular arrhythmias … or anti-tachycardia pacing and ‘post-shock’ pacing are not …

The role of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome

I Goldenberg, DT Huang, JC Nielsen - European heart journal, 2020 - academic.oup.com
antitachycardia pacing (ATP) based on device programming. … of ventricular arrhythmias and
appropriate ICD therapies, 54 … Statement on Optimal Implantable Cardioverter-Defibrillator

Perioperative Management of Patients with Cardiac Implantable Electronic Devices

M Kim, CH Kwon - Korean Journal of Anesthesiology, 2024 - ekja.org
… , which increases the paced 4 rate to optimize cardiac output. … inappropriate anti-tachycardia
pacing (ATP) or shock therapy… a patient with an implantable cardioverter defibrillator (ICD) …

The use of cardiac stereotactic radiation therapy (SBRT) to manage ventricular tachycardia: a case report, review of the literature and technical notes

S Cozzi, N Bottoni, A Botti, V Trojani, E Alì… - Journal of Personalized …, 2022 - mdpi.com
cardioverter defibrillator implant after atrial ventricular node … device shock after ineffective
antitachycardia pacing (ATP). … computed tomography (CT), optimal dose, and long-term …

… of guideline-based medical therapy with malignant arrhythmias and mortality among heart failure patients implanted with cardioverter defibrillator (ICD) or cardiac …

T Hasin, I Davarashvili, Y Michowitz, R Farkash… - Journal of Clinical …, 2021 - mdpi.com
… patients treated with optimal medical management including … an appropriate anti-tachycardia
pacing (ATP) or shock therapy … 24–30 beats, treated via ATP during charge and thereafter …

Flecainide how and when: a practical guide in supraventricular arrhythmias

C Lavalle, M Magnocavallo, M Straito, L Santini… - Journal of Clinical …, 2021 - mdpi.com
… could increase atrial anti-tachycardia pacing efficacy that … with VT and implantable cardioverter
defibrillator, flecainide … addition to optimization of medical therapy when catheter ablation …